303 related articles for article (PubMed ID: 36399325)
1. Cancer-Associated Fibroblasts in Inflammation and Antitumor Immunity.
Kennel KB; Bozlar M; De Valk AF; Greten FR
Clin Cancer Res; 2023 Mar; 29(6):1009-1016. PubMed ID: 36399325
[TBL] [Abstract][Full Text] [Related]
2. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.
Zhang H; Yue X; Chen Z; Liu C; Wu W; Zhang N; Liu Z; Yang L; Jiang Q; Cheng Q; Luo P; Liu G
Mol Cancer; 2023 Oct; 22(1):159. PubMed ID: 37784082
[TBL] [Abstract][Full Text] [Related]
3. Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma.
Neuzillet C; Nicolle R; Raffenne J; Tijeras-Raballand A; Brunel A; Astorgues-Xerri L; Vacher S; Arbateraz F; Fanjul M; Hilmi M; Samain R; Klein C; Perraud A; Rebours V; Mathonnet M; Bièche I; Kocher H; Cros J; Bousquet C
J Pathol; 2022 Dec; 258(4):408-425. PubMed ID: 36102377
[TBL] [Abstract][Full Text] [Related]
4. Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts.
Elyada E; Bolisetty M; Laise P; Flynn WF; Courtois ET; Burkhart RA; Teinor JA; Belleau P; Biffi G; Lucito MS; Sivajothi S; Armstrong TD; Engle DD; Yu KH; Hao Y; Wolfgang CL; Park Y; Preall J; Jaffee EM; Califano A; Robson P; Tuveson DA
Cancer Discov; 2019 Aug; 9(8):1102-1123. PubMed ID: 31197017
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
6. Cancer-Associated Fibroblasts Suppress CD8+ T-cell Infiltration and Confer Resistance to Immune-Checkpoint Blockade.
Jenkins L; Jungwirth U; Avgustinova A; Iravani M; Mills A; Haider S; Harper J; Isacke CM
Cancer Res; 2022 Aug; 82(16):2904-2917. PubMed ID: 35749591
[TBL] [Abstract][Full Text] [Related]
7. From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts.
Arpinati L; Scherz-Shouval R
Trends Cancer; 2023 May; 9(5):421-443. PubMed ID: 36870916
[TBL] [Abstract][Full Text] [Related]
8. The roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas.
Mezawa Y; Orimo A
Cell Tissue Res; 2016 Sep; 365(3):675-89. PubMed ID: 27506216
[TBL] [Abstract][Full Text] [Related]
9. Clinical and therapeutic relevance of cancer-associated fibroblasts.
Chen Y; McAndrews KM; Kalluri R
Nat Rev Clin Oncol; 2021 Dec; 18(12):792-804. PubMed ID: 34489603
[TBL] [Abstract][Full Text] [Related]
10. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
Yoshida GJ
J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion.
Hao J; Zeltz C; Pintilie M; Li Q; Sakashita S; Wang T; Cabanero M; Martins-Filho SN; Wang DY; Pasko E; Venkat K; Joseph J; Raghavan V; Zhu CQ; Wang YH; Moghal N; Tsao MS; Navab R
Neoplasia; 2019 May; 21(5):482-493. PubMed ID: 30978569
[TBL] [Abstract][Full Text] [Related]
12. Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.
Zou R; Jiang Q; Jin T; Chen M; Yao L; Ding H
Front Immunol; 2022; 13():956224. PubMed ID: 36032075
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
Ravichandra A; Bhattacharjee S; Affò S
Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
[TBL] [Abstract][Full Text] [Related]
14. Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.
Akkız H
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835352
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts: Just on the opposite side of antitumour immunity?
Guo S; Yuan J; Meng X; Feng X; Ma D; Han Y; Li K
Int Immunopharmacol; 2023 Sep; 122():110601. PubMed ID: 37418988
[TBL] [Abstract][Full Text] [Related]
16. CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer.
Houthuijzen JM; de Bruijn R; van der Burg E; Drenth AP; Wientjens E; Filipovic T; Bullock E; Brambillasca CS; Pulver EM; Nieuwland M; de Rink I; van Diepen F; Klarenbeek S; Kerkhoven R; Brunton VG; Scheele CLGJ; Boelens MC; Jonkers J
Nat Commun; 2023 Jan; 14(1):183. PubMed ID: 36635273
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts: from basic science to anticancer therapy.
Yang D; Liu J; Qian H; Zhuang Q
Exp Mol Med; 2023 Jul; 55(7):1322-1332. PubMed ID: 37394578
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of Cancer-Associated Fibroblasts and the Tumor Immune Microenvironment in Pancreatic Cancer.
Shinkawa T; Ohuchida K; Nakamura M
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010986
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk of tumor stromal cells orchestrates invasion and spreading of gastric cancer.
Tanaka M
Pathol Int; 2022 Apr; 72(4):219-233. PubMed ID: 35112770
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response.
Xiao Y; Wang Z; Gu M; Wei P; Wang X; Li W
Clin Exp Med; 2024 Jun; 24(1):126. PubMed ID: 38864912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
